Health Holland
Eureka Biotech Call 2026
€400k–€750k per project (Dutch partners)| Deadline: 25 September 2026 (102 days)
Central EUREKA submission + national documentation required; Dutch consortia encouraged to notify RVO and Health Holland in advance
Last verified:
Details
| Funder | Health Holland |
| Budget | €400k–€750k per project (Dutch partners) |
| Deadline | 25 September 2026 |
| Consortium | Required — at least 2 Dutch partners (1 company + 1 research organisation) and at least 2 partners from a priority country (1 company + 1 research organisation); priority countries: Belgium, France, Germany, Singapore, Spain, Sweden, Switzerland |
| Application | 2-stage: central EUREKA submission portal, then national submission portal |
| TRL | 4-7 |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
PPP subsidy for Dutch SMEs and research organisations participating in international R&D consortia focused on cell and gene therapies (CGT) and Organ-on-Chip (OoC) technologies (TRL 4–7). Healthcare providers and foundations are not eligible. International partners must secure their own funding. Co-funding (in-kind and/or cash) by all partners is required.
More from Health Holland
Browse all open grants →Browse Related
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free